Controls antibodies used here include VRC01, a human neutralizing mAb against HIV-1, c13C6 and KZ52, previously isolated neutralizing mAbs against EBOV. In live EBOV experiment (c), neutralizing activity was evaluated in the presence (dark) and absence (light) of complement in comparison with...
The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detec...
22. Diagnostic kits for antibody immunoassay wherein monoclonal and/or polyclonal antibodies of claim 7 are arrayed on a solid support for example wells or microarrays for fluids detection of Fru-AGEs and/or Fru-AGEs macro-molecules. a) The method of claim 7 wherein antibodies are organized an...